CDH2 and hepatocellular carcinoma: Interestingly, CDH1 and CDH2 up-regulation in HCC tissues was associated with a lower recurrence rate and a longer TTR (Supplementary Figure 2A, 2B) as observed for CASC9 and LUCAT1.